Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin Bart

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Journal of Addiction Medicine|September 2, 2017
Methadone and the QTc Interval: Paucity of Clinically Significant Factors in a Retrospective CohortGavin Bart, Zachary Wyman, Qi Wang, et al.
Addiction (Abingdon, England)|March 15, 2008
Markers for hepatitis A, B and C in methadone maintained patients: an unexpectedly high co-infection with silent hepatitis BGavin Bart, Paola Piccolo, Linqi Zhang, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 24, 2006
Altered levels of basal cortisol in healthy subjects with a 118G allele in exon 1 of the Mu opioid receptor geneGavin Bart, K Steven LaForge, Lisa Borg, et al.
Journal of Addiction Medicine|September 2, 2020
Associations Between Polysubstance Use Patterns and Receipt of Medications for Opioid Use Disorder Among Adults in Treatment for Opioid Use DisorderBecky R Ford, Gavin Bart, Brian Grahan, et al.
Addiction Biology|April 22, 2011
Mu-opioid receptor A118G polymorphism in healthy volunteers affects hypothalamic-pituitary-adrenal axis adrenocorticotropic hormone stress response to metyraponeElizabeth Ducat, Brenda Ray, Gavin Bart, et al.
BMC Primary Care|October 11, 2024
Predicting buprenorphine adherence among patients with opioid use disorder in primary care settingsStephanie A Hooker, Colleen Starkey, Gavin Bart, et al.
Journal of General Internal Medicine|August 8, 2023
Hospital Addiction Medicine Consultation Service Orders and Outcomes by Patient Race and Ethnicity in an Urban, Safety-Net HospitalAmber R Lindsay, Tyler N A Winkelman, Gavin Bart, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 1, 2005
Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?Gavin Bart, James H Schluger, Lisa Borg, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 5, 2004
Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central SwedenGavin Bart, Mary Jeanne Kreek, Jurg Ott, et al.
Addiction Biology|June 15, 2007
Prodynorphin gene promoter repeat associated with cocaine/alcohol codependenceTanya J Williams, K Steven LaForge, Derek Gordon, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Journal of Addiction Medicine|September 2, 2017
Methadone and the QTc Interval: Paucity of Clinically Significant Factors in a Retrospective CohortGavin Bart, Zachary Wyman, Qi Wang, et al.
Addiction (Abingdon, England)|March 15, 2008
Markers for hepatitis A, B and C in methadone maintained patients: an unexpectedly high co-infection with silent hepatitis BGavin Bart, Paola Piccolo, Linqi Zhang, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 24, 2006
Altered levels of basal cortisol in healthy subjects with a 118G allele in exon 1 of the Mu opioid receptor geneGavin Bart, K Steven LaForge, Lisa Borg, et al.
Journal of Addiction Medicine|September 2, 2020
Associations Between Polysubstance Use Patterns and Receipt of Medications for Opioid Use Disorder Among Adults in Treatment for Opioid Use DisorderBecky R Ford, Gavin Bart, Brian Grahan, et al.
Addiction Biology|April 22, 2011
Mu-opioid receptor A118G polymorphism in healthy volunteers affects hypothalamic-pituitary-adrenal axis adrenocorticotropic hormone stress response to metyraponeElizabeth Ducat, Brenda Ray, Gavin Bart, et al.
BMC Primary Care|October 11, 2024
Predicting buprenorphine adherence among patients with opioid use disorder in primary care settingsStephanie A Hooker, Colleen Starkey, Gavin Bart, et al.
Journal of General Internal Medicine|August 8, 2023
Hospital Addiction Medicine Consultation Service Orders and Outcomes by Patient Race and Ethnicity in an Urban, Safety-Net HospitalAmber R Lindsay, Tyler N A Winkelman, Gavin Bart, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 1, 2005
Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?Gavin Bart, James H Schluger, Lisa Borg, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 5, 2004
Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central SwedenGavin Bart, Mary Jeanne Kreek, Jurg Ott, et al.
Addiction Biology|June 15, 2007
Prodynorphin gene promoter repeat associated with cocaine/alcohol codependenceTanya J Williams, K Steven LaForge, Derek Gordon, et al.
Pageof 9